Susquehanna International Group’s Evolent Health EVH Stock Holding History

Susquehanna International Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.7K	Sell	11,700 -1,300	-10%	-$4.12K	﹤0.01%	12799
2025 Q4	$52K	Sell	13,000 -116,900	-90%	-$650K	﹤0.01%	11737
2025 Q3	$1.1M	Sell	129,900 -17,800	-12%	-$173K	﹤0.01%	7126
2025 Q2	$1.66M	Sell	147,700 -13,000	-8%	-$119K	﹤0.01%	6189
2025 Q1	$1.52M	Sell	160,700 -135,900	-46%	-$1.37M	﹤0.01%	6175
2024 Q4	$3.34M	Buy	296,600 +99,900	+51%	+$1.76M	﹤0.01%	4264
2024 Q3	$5.56M	Sell	196,700 -17,500	-8%	-$451K	﹤0.01%	3438
2024 Q2	$4.1M	Buy	214,200 +78,900	+58%	+$2.01M	﹤0.01%	3777
2024 Q1	$4.44M	Buy	135,300 +80,400	+146%	+$2.57M	﹤0.01%	3821
2023 Q4	$1.81M	Buy	54,900 +27,400	+100%	+$775K	﹤0.01%	5578
2023 Q3	$749K	Buy	27,500 +12,200	+80%	+$339K	﹤0.01%	7295
2023 Q2	$464K	Sell	15,300 -9,500	-38%	-$307K	﹤0.01%	8500
2023 Q1	$805K	Sell	24,800 -43,700	-64%	-$1.38M	﹤0.01%	7394
2022 Q4	$1.92M	Sell	68,500 -52,900	-44%	-$1.52M	﹤0.01%	4771
2022 Q3	$4.36M	Buy	121,400 +109,300	+903%	+$3.85M	﹤0.01%	3392
2022 Q2	$372K	Sell	12,100 -18,100	-60%	-$527K	﹤0.01%	8977
2022 Q1	$975K	Sell	30,200 -20,600	-41%	-$539K	﹤0.01%	7188
2021 Q4	$1.41M	Sell	50,800 -27,200	-35%	-$780K	﹤0.01%	6376
2021 Q3	$2.42M	Buy	78,000 +28,300	+57%	+$679K	﹤0.01%	5428
2021 Q2	$1.05M	Sell	49,700 -18,100	-27%	-$363K	﹤0.01%	7632
2021 Q1	$1.37M	Buy	67,800 +52,300	+337%	+$995K	﹤0.01%	6903
2020 Q4	$248K	Sell	15,500 -38,000	-71%	-$502K	﹤0.01%	9661
2020 Q3	$664K	Buy	+53,500	New	+$629K	﹤0.01%	7075
2020 Q2	–	Sell	-20,600	Closed	-$112K	–	10311
2020 Q1	$112K	Sell	20,600 -161,500	-89%	-$1.44M	﹤0.01%	9239
2019 Q4	$1.65M	Buy	+182,100	New	+$1.48M	﹤0.01%	4640
2019 Q3	–	Sell	-25,900	Closed	-$206K	–	10329
2019 Q2	$206K	Sell	25,900 -88,300	-77%	-$1.05M	﹤0.01%	9073
2019 Q1	$1.44M	Buy	114,200 +58,400	+105%	+$925K	﹤0.01%	4308
2018 Q4	$1.11M	Buy	55,800 +31,300	+128%	+$724K	﹤0.01%	4474
2018 Q3	$696K	Sell	24,500 -5,000	-17%	-$119K	﹤0.01%	5943
2018 Q2	$621K	Sell	29,500 -15,900	-35%	-$301K	﹤0.01%	6375
2018 Q1	$647K	Buy	45,400 +9,500	+26%	+$136K	﹤0.01%	6127
2017 Q4	$442K	Sell	35,900 -34,100	-49%	-$481K	﹤0.01%	6869
2017 Q3	$1.25M	Sell	70,000 -53,500	-43%	-$1.1M	﹤0.01%	4856
2017 Q2	$3.13M	Sell	123,500 -28,900	-19%	-$695K	﹤0.01%	3084
2017 Q1	$3.4M	Buy	152,400 +11,000	+8%	+$211K	﹤0.01%	2845
2016 Q4	$2.09M	Buy	141,400 +119,400	+543%	+$2.35M	﹤0.01%	3967
2016 Q3	$542K	Buy	+22,000	New	+$514K	﹤0.01%	5925

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's EVH Position: Q1 2026 in Review

Susquehanna International Group reduced its Evolent Health (EVH) stake by 58% in Q1 2026, selling an estimated $399K and leaving 91,537 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #11622.

Susquehanna International Group first reported a position in EVH in Q3 2015 and has held it in 37 quarters since. The position peaked at $4.68M in Q3 2021. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Susquehanna International Group held 91,537 shares of Evolent Health worth $209K as of Q1 2026.
Susquehanna International Group sold 125,810 Evolent Health shares in Q1 2026, an estimated $399K.
Evolent Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11622 holding.
Susquehanna International Group first reported a position in Evolent Health in Q3 2015 and has held it in 37 quarters since.
Susquehanna International Group's Evolent Health position peaked at $4.68M in Q3 2021.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.